C07K 2317/622
Single chain antibody
Official title: Single chain antibody (scFv)
C07K2317/622 (Single chain antibody) appears on 6,039 US grants and 12,248 published applications in this corpus.
Search patents in C07K- Granted patents
- 6,039
- Published applications
- 12,248
- Assignees
- 3,059
- Inventors
- 17,316
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 5 | 0 |
| 1997 | 11 | 0 |
| 1998 | 18 | 0 |
| 1999 | 39 | 0 |
| 2000 | 34 | 0 |
| 2001 | 32 | 10 |
| 2002 | 42 | 77 |
| 2003 | 42 | 151 |
| 2004 | 25 | 134 |
| 2005 | 32 | 182 |
| 2006 | 51 | 165 |
| 2007 | 50 | 130 |
| 2008 | 64 | 154 |
| 2009 | 91 | 183 |
| 2010 | 101 | 205 |
| 2011 | 112 | 233 |
| 2012 | 148 | 213 |
| 2013 | 135 | 258 |
| 2014 | 153 | 307 |
| 2015 | 198 | 337 |
| 2016 | 265 | 524 |
| 2017 | 275 | 571 |
| 2018 | 290 | 623 |
| 2019 | 359 | 691 |
| 2020 | 438 | 867 |
| 2021 | 468 | 1016 |
| 2022 | 490 | 1068 |
| 2023 | 471 | 1092 |
| 2024 | 572 | 1233 |
| 2025 | 609 | 1035 |
| 2026 | 409 | 789 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cell-receptor targeted exosomes6 Oct 2026US 12,751,930 B2City of Hope
- Bispecific chimeric antigen receptors targeting CD20 and BCMA6 Oct 2026US 12,751,973 B2Abelzeta Inc.
- BCMA chimeric antigen receptors6 Oct 2026US 12,752,006 B2Regeneron Pharmaceuticals, Inc.
- Inducible chimeric antigen receptor and application thereof6 Oct 2026US 12,752,007 B2Beijing Tiantan Hospital, Capital Medical University
- Mesothelin specific chimeric antigen receptors (CAR) for solid tumors cancer immunotherapy6 Oct 2026US 12,753,220 B2Cellectis
- Lipid nanoparticles and methods of manufacture and use thereof8 Oct 2026US 2026/0306659 A1Ablynx N. V.
- Nk cell compositions and preparations for immunotherapy and methods for their production8 Oct 2026US 2026/0308226 A1Deverra Therpaeutics Inc.
- Anti-vegf protein compositions and methods for producing the same8 Oct 2026US 2026/0308231 A1Regeneron Pharmaceuticals, Inc.
- Anti-vegf protein compositions and methods for producing the same8 Oct 2026US 2026/0308232 A1Regeneron Pharmaceuticals, Inc.
- Anti-vegf protein compositions and methods for producing the same8 Oct 2026US 2026/0308233 A1Regeneron Pharmaceuticals, Inc.
Most cited
By later US patents
- Production of chimeric antibodies - a combinatorial approach1,367US 5,565,332 ACambridge Antibody Technology Limited · 1996
- Methods for producing members of specific binding pairs893US 5,969,108 ACambridge Antibody Technology Limited · 1999
- Methods for in vitro recombination882US 5,605,793 AAffymax Technologies N.V. · 1997
- Methods for producing members of specific binding pairs849US 5,733,743 ACambridge Antibody Technology Limited · 1998
- Methods and compositions for cellular and metabolic engineering844US 5,837,458 AMaxygen, Inc. · 1998